Trial Profile
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2012
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 01 Apr 2012 Results published in the Journal of Clinical Pharmacy and Therapeutics.
- 06 Mar 2011 New trial record